Enterome

Enterome to Present Three Abstracts on its Novel OncoMimics™ Cancer Immunotherapies at ASCO 2022

Paris, France - May 27, 2022: Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its bacterial Mimicry drug discovery platform, today announced the publication of three abstracts related to its OncoMimcs™ pipeline, including EO2401, its first-in-class off-the-shelf OncoMimics™ cancer immunotherapy, ahead of poster presentations at the American Society of Clinical Oncology...
94/96 avenue Ledru-Rollin 75011 Paris

+33 (0)1 75 77 27 85